^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Breast Cancer |
| Drug Class: | Aromatase inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Recommendation 2. Women with node-positive breast cancer should be offered extended AI therapy for up to a total of 10 years of adjuvant endocrine treatment.
DOI:
10.1200/JCO.18.01160
